Assessment of CCM in HF With Higher Ejection Fraction (NCT05064709)
Assessment of Implantable CCM in the Heart Failure Group With Higher Ejection Fraction
🩺 Plain-English Summary (8th-Grade Level)
The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥40% and ≤70%.
Who can join: Review the eligibility criteria below.
Location: Grandview Medical Group Research, LLC — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (105 Sites)
Showing the first 25 of 105 sites.
- Grandview Medical Group Research, LLC — Birmingham, Alabama
- CardioVascular Associates of Mesa — Mesa, Arizona
- Chan Heart Rhythm Institute — Mesa, Arizona
- Southwest Cardiovascular Associates — Mesa, Arizona
- Arizona Heart Rhythm — Phoenix, Arizona
- Cardiovascular Consultants, Ltd — Phoenix, Arizona
- HonorHealth — Scottsdale, Arizona
- Pima Heart and Vascular — Tuscon, Arizona
- John Muir Health — Concord, California
- University of California San Diego — La Jolla, California
- USC Keck School of Medicine — Los Angeles, California
- Cedars Sinai Medical Center — Los Angeles, California
- Valley Clinical Trials- Northridge — Northridge, California
- Sequoia Hospital — Redwood City, California
- University of California Davis Health — Sacramento, California
- University of California, San Francisco — San Francisco, California
- Nuvance Health - Danbury Hospital — Danbury, Connecticut
- Hartford Healthcare — Hartford, Connecticut
- HCA Florida JFK Hospital — Atlantis, Florida
- Nouvelle Clinical Research LLC — Cutler Bay, Florida
- Broward Health — Fort Lauderdale, Florida
- Memorial Healthcare System — Hollywood, Florida
- Baptist Health South Florida — Miami, Florida
- NCA Research Institute - Florida — Naples, Florida
- AdventHealth Orlando — Orlando, Florida
📞 Contact the Study Coordinator
Phone: (856) 642-9933
Email: aimhigher@impulsedynamics.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Heart Failure
- REDUCE LAP-HFREF TRIAL — New York, New York
- Physiological Effects Ketone Ester in Heart — Cleveland, Ohio
- DASH Diet in Heart Failure Outpatients — Sacramento, California
- Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients — Huntsville, Alabama
- LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. — Birmingham, Alabama
- A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation — Alexander City, Alabama
Explore by condition: All Heart Failure clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.